Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury - Trial NCT06264752
Access comprehensive clinical trial information for NCT06264752 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pittsburgh and is currently Enrolling by invitation. The study focuses on Acute Kidney Injury. Target enrollment is 625 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Pittsburgh
Timeline & Enrollment
N/A
Feb 15, 2024
Apr 01, 2026
Primary Outcome
Major Adverse Kidney Events within 30 days of randomization (MAKE30)
Summary
This study is a randomized controlled trial at eight hospitals within the University of
 Pittsburgh Medical Center-UPMC system. The project will assess the efficacy of a clinical
 surveillance system augmented with real-time predictive analytics to support a pharmacist-led
 intervention delivered to attending physicians (primary service) to reduce the progression
 and complications of drug-associated acute kidney injury (D-AKI) in hospitalized (non-ICU)
 adults.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06264752
Non-Device Trial